PROUS INSTITUTE PRESENTS THE 11TH EDITION OF THE PROUS INSTITUTE - OVERTON & MEYER AWARD FOR NEW TECHNOLOGIES IN DRUG DISCOVERY TO PROF. VÉRONIQUE GOUVERNEUR
Prous Institute for Biomedical Research is to present the 2024 Prous Institute – Overton & Meyer Award to Professor Véronique Gouverneur, at the XXVIII International Symposium on Medicinal Chemistry organized by the European Federation of Medicinal Chemistry (EFMC).
The award, conferred every two years since 2004 and now in its eleventh edition, recognizes outstanding contributions to the development of new technologies in the field of medicinal chemistry and acknowledges the awardee’s contribution to the discovery and development of innovative technologies that advance the field.
Prof. Gouverneur is a recognized leader in the field for her significant contributions to fluorine chemistry and its applications in medicine and Positron Emission Tomography (PET) imaging. Major highlights of her contributions include over 45 fluorination reactions invented and groundbreaking methods for 18F-radiolabeling.
Prof. Gouverneur is the Waynflate Professor of Chemistry at Magdalen College, in the Department of Chemistry at Oxford University, where she founded and directs the Véronique Gouverneur Group focusing on exciting new approaches to address long-standing problems in the synthesis of fluorinated molecules including pharmaceutical drugs and probes for imaging.
The award will be presented during the XXVIII International Symposium on Medicinal Chemistry (EFMC-ISMC 2024), to be held in Rome, Italy, on September 1 – September 5, 2024. The Award plenary Lecture is scheduled for Tuesday, September 3 at 8:30 a.m. CET.
About the Prous Institute for Biomedical Research
Prous Institute for Biomedical Research, created as a spin-off of Prous Science (acquired by Thomson Reuters, now Clarivate Analytics, in 2007) is committed to supporting the discovery of novel therapeutic and diagnostic approaches.
Originally founded by Dr. J.R. Prous, Prous Institute has evolved to expand its mission beyond its own developments by partnering and investing in transformative science initiatives.
By leveraging more than 60 years’ experience in the life sciences, we offer the resources and capabilities needed by researchers to move their research closer to the patient bedside.
About the European Federation of Medicinal Chemistry (EFMC)
The EFMC is an independent association representing medicinal chemistry societies in Europe. Its objective is to advance the science of medicinal chemistry by promoting cooperation and networking, by providing training and mentoring, by rewarding scientific excellence, and by facilitating communication and influencing stakeholders.